Respiratory Viral Transmission Network
Respiratory Viral Transmission Network
Sponsor: Centers for Disease Control and Prevention CDC
Enrolling: Male and Female Patients
IRB Number: AAAU0181
Contact: Celibell Vargas: /
Additional Study Information: The purpose of this study is to assess the effectiveness of influenza and SARS-CoV-2 vaccines for preventing transmission of infections in households. We are seeking volunteers who have been recently diagnosed with COVID-19 or Influenza virus infection by either rapid diagnostic assay or RT-PCR in the last 7 days and live in a household with at least one other person. The study, also known as RVTN Sentinel Respiratory VirusTransmission Network will be looking at household transmission of SARS-CoV-2 and/or influenza. Once someone and their household contacts are enrolled, they will be followed for 10 consecutive days to identify new viruses infections among household members. Follow-up will include interviews/questionnaires, self-collection of a fingerstick of blood for the person who tested positive, daily data collection from all participating household members for 10 days, daily self-collected nasal swabs from all participating household members, remote video/telephone visits during the follow-up period, and an option self-collection of a blood specimen 46 weeks after enrollment. All study visits will be remote ie no one has to come to the medical center. Households will be compensated up to $250.
This study is closed
Melissa Stockwell, MD, MPH
Do You Qualify?
Have you been diagnosed with COVID-19 or influenza by either rapid or PCR test in the last 7 days? Yes No
Was your rapid or PCR test taken at Columbia University Irving Medical Center/NewYork-Presbyterian Hospital? Yes No
Do you live in a household with at least one other person? Yes No
Do you speak English or Spanish? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Celibell Vargas